Form D · Other Health Care
SpringWorks Therapeutics, Inc.
Stamford, CT · CIK 0001773427
Offering snapshot reported Apr 12, 2019 · SEC filing
- Reported sold
- $125M Offering amount: $125M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 29, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 12, 2019 | Initial | $125,003,152 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-337163
Source: Form D, filed Apr 12, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carl L Gordon | Director |
| Michael Greco | Executive |
| Saqib Islam | Director, Executive |
| Peter Keen | Director |
| Freda Lewis Hall | Director |
| Daniel S. Lynch | Director, Executive |
| Deval Patrick | Director |
| Jeffrey Schwartz | Director |
| Stephen Squinto | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
100 Washington Boulevard
Stamford, CT, 06902
Stamford, CT, 06902